Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease

The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson’s disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Tykalova, Tereza, Novotny, Michal, Ruzicka, Evzen, Dusek, Petr, Rusz, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901688/
https://www.ncbi.nlm.nih.gov/pubmed/35256614
http://dx.doi.org/10.1038/s41531-022-00286-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901688/
https://www.ncbi.nlm.nih.gov/pubmed/35256614
http://dx.doi.org/10.1038/s41531-022-00286-y

Ejemplares similares